Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
Hamada T, Sugaya M, Tokura Y, Ohtsuka M, Tsuboi R, Nagatani T, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Yoshida T, Saida T, Iwatsuki K.
Hamada T, et al. Among authors: setoyama m.
J Dermatol. 2017 Feb;44(2):135-142. doi: 10.1111/1346-8138.13542. Epub 2016 Aug 20.
J Dermatol. 2017.
PMID: 27543197
Clinical Trial.